Lv2
200 积分 2022-02-18 加入
DNMT1 inhibition reprograms T cells to NK-like cells with potent antitumor activity
13天前
已完结
CD28 co-stimulation: novel insights and applications in cancer immunotherapy
26天前
已完结
SYK negatively regulates ITAM-mediated human NK cell signaling and CD19-CAR NK cell efficacy
29天前
已完结
ZAP327 signaling domain–driven chimeric antigen receptor generates robust and long-term antitumor immunity in mouse models
29天前
已完结
Intraperitoneal infusion of NKG2D CAR-NK cells induces endogenous CD8+ T cell activation in patients with advanced colorectal cancer
1个月前
已完结
Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial
1个月前
已完结
Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial
1个月前
已完结
皖公网安备34019202002308
